TIANJIN TEDA BIOMEDICAL ENGINEERING COMPANY LIMITED

Tianjin TEDA Biomedical Engineering Company Limited

8189

CNE1000004H7

Agricultural Chemicals

Delayed Hong Kong S.E. Other stock markets 09:08:20 14/05/2024 BST			5-day change	1st Jan Change
0.078 ^HKD	+14.71%		+5.41%	-12.36%

03-28	Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
03-28	Tianjin TEDA Biomedical Engineering Company Limited Announces Resignation of Mr. Li Xudong as Independent Non-Executive Director and Chairman of the Audit Committee	CI

Tianjin TEDA Biomedical Engineering Company Limited Announces Resignation of Gai Li as Non-Executive Director

March 26, 2021 at 02:53 pm

Tianjin TEDA Biomedical Engineering Company Limited announced that the Board has accepted the resignation of Ms. Gai Li as non-executive Director with effect from 26 March 2021.

Latest news about Tianjin TEDA Biomedical Engineering Company Limited

Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	03-28	CI
Tianjin TEDA Biomedical Engineering Company Limited Announces Resignation of Mr. Li Xudong as Independent Non-Executive Director and Chairman of the Audit Committee	03-28	CI
An undisclosed buyer agreed to acquire an unknown stake in Shanghai Weidi Network Technology Company Limited from Tianjin TEDA Biomedical Engineering Company Limited	03-26	CI
Tianjin TEDA Biomedical Engineering Company Limited Announces Chief Executive Officer Changes	03-26	CI
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09	CI
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23	CI
Tianjin TEDA Biomedical Engineering Company Limited Announces Change of Principal Place of Business in Hong Kong	14/06/23	CI
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23	CI
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23	CI
Tianjin TEDA Biomedical Engineering Company Limited Announces Mr. Hao Zhihui Will Retire as an Executive Director	14/11/22	CI
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	10/11/22	CI
Tianjin Teda Biomedical Engineering Company Limited Announces Executive Changes	06/09/22	CI
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	09/08/22	CI
Tianjin TEDA Biomedical Engineering Company Limitedcompleted the acquisition of Shanghai Weidi Network Technology Company from three shareholders.	30/07/22	CI
Tianjin TEDA Biomedical Engineering Company Limited entered into the Equity Transfer Agreement to acquire Shanghai Weidi Network Technology Company from three shareholders for CNY12.8 million.	17/07/22	CI
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022	10/05/22	CI
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021	31/03/22	CI
Tianjin Teda Biomedical Engineering Company Limited Announces Delay in Publication and Despatch of Annual Report for the Year	24/03/22	CI
Tianjin TEDA Biomedical Engineering Company Limited Approves Appointment of Mr. Zhao Zhiyou as the Independent Supervisor	08/02/22	CI
Wang Shuxin entered into the Equity Transfer Agreement to acquire 30.2653% stake in Tianjin Alpha Healthcare Products Co., Ltd. from Tianjin TEDA Biomedical Engineering Company Limited for CNY 10.86 million.	27/12/21	CI
Tianjin TEDA Biomedical Engineering Company Limited Announces Resignation of Feng Ling as Independent Supervisor	20/12/21	CI
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	10/11/21	CI
Tianjin Teda Biomedical Engineering Company Limited Reports Earnings Results for the Second Quarter Ended June 30, 2021	09/08/21	CI
Tianjin Teda Biomedical Engineering Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2021	10/05/21	CI
Tianjin TEDA Biomedical Engineering Company Limited Announces Resignation of Gai Li as Non-Executive Director	26/03/21	CI

Chart Tianjin TEDA Biomedical Engineering Company Limited

Duration

Period

Chart Tianjin TEDA Biomedical Engineering Company Limited

More charts

Tianjin TEDA Biomedical Engineering Company Limited is a China-based company principally engaged in the research and development, commercialization, manufacturing and sales of biological compound fertilizer products. Its primary products include the series of biological compound fertilizer products for the promotion of balanced growth of grains, fruits and vegetables. These products are mainly sold under the brand of Fulilong. The Companyâs businesses are mainly conducted in the Peopleâs Republic of China (the PRC). The Companyâs principal subsidiaries include Shandong Hidersun Fertiliser Industry Co., Ltd. and Guangdong Fulilong Compound Fertiliser Co., Ltd.

Sector

Agricultural Chemicals

Calendar

10/11/2024 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Fertilizer

	1st Jan change	Capi.
TIANJIN TEDA BIOMEDICAL ENGINEERING COMPANY LIMITED	-12.36%	18.92M
SABIC AGRI-NUTRIENTS COMPANY	-20.41%	13.96B
CF INDUSTRIES HOLDINGS, INC.	-5.89%	13.68B
QINGHAI SALT LAKE INDUSTRY CO.,LTD	+11.85%	13.26B
THE MOSAIC COMPANY	-15.45%	9.71B
ACRON	-.--%	7.4B
FERTIGLOBE PLC	-12.46%	5.88B
COROMANDEL INTERNATIONAL LIMITED	-1.29%	4.36B
ASIA-POTASH INTERNATIONAL INVESTMENT (GUANGZHOU)CO.,LTD.	-25.04%	2.5B
YONFER AGRICULTURAL TECHNOLOGY CO., LTD.	+12.82%	2.28B